Next-Gen Immunotherapy Optimization Using Deep Molecular Interaction Networks

Improving lung cancer immunotherapy necessitates better biomarker identification, predictive modeling, and treatment analysis, with challenges in T cell expansion from reagents and contamination. Prognostic evaluations depend on cancer cell arrangement, tumor-infiltrating lymphocytes, and gene alterations. To address this, issue a new technique is developed the Lung Cancer Immunotherapy Optimization Through Integrated Molecular Interaction (LCIOIM) model by utilizing multimodal data, including clinical, genomic, radiographic, and immunological data, from 1, 435 NSCLC patients treated during 2010 to 2025. The Patient Feature Encoder (PFE) employs multi-layer perceptron networks to correlate transcriptome and pathway data with unique signatures. The Immune Evasion vs. Neoantigen Silencing Module uses a tumor dynamics model to assess immunotherapy resistance. The Immunotherapy Sensitivity Calculation (ISC) estimates treatment effectiveness based on Tumor Mutational Burden (TMB), immune checkpoint activity, HLA expression, markers of immunogenic cell death, and mRNA vaccine responsiveness. Mamdani and Sugeno systems enable transparent clinical decision-making. The Image and Data Analysis module assesses tumor cell proliferation and morphology through geometric modeling. The Classification Process employs ensemble methods and SVM classifiers, optimized with MobileNetV3-Small feature vectors. A Hierarchical Multi-Scale Transformer (HMT) learns semantic representations across scales. Additionally, a Semi-Supervised Adversarial Learning Mechanism improves biomarker prediction using labeled and unlabeled data. The Multi-Objective Loss Function Framework integrates focal classification loss, modality-specific learning loss, and cosine alignment loss for effective feature fusion and reliable predictions.

Authors

Institutions

Publication Details

Journal
The International Journal of Maritime Engineering
Published
2026-11-13
DOI
https://doi.org/10.5750/ijme.v168ia6(s).2082
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Next-Gen Immunotherapy Optimization Using Deep Molecular Interaction Networks

Sanaboina Leela Krishna, Masthan Rao Kale, Sreelalitha Talluri, Nidamanuri Srinu et al.
4 links
The International Journal of Maritime Engineering
Cancer Immunotherapy and Biomarkers
article

Next-Gen Immunotherapy Optimization Using Deep Molecular Interaction Networks

Sanaboina Leela Krishna, Masthan Rao Kale, Sreelalitha Talluri, Nidamanuri Srinu, M. Ayyappa Chakravarthi, T. V. Sai Krishna, Sriharsha Vikruthi, B. Ranga Swamy
article en

Abstract

Improving lung cancer immunotherapy necessitates better biomarker identification, predictive modeling, and treatment analysis, with challenges in T cell expansion from reagents and contamination. Prognostic evaluations depend on cancer cell arrangement, tumor-infiltrating lymphocytes, and gene alterations. To address this, issue a new technique is developed the Lung Cancer Immunotherapy Optimization Through Integrated Molecular Interaction (LCIOIM) model by utilizing multimodal data, including clinical, genomic, radiographic, and immunological data, from 1, 435 NSCLC patients treated during 2010 to 2025. The Patient Feature Encoder (PFE) employs multi-layer perceptron networks to correlate transcriptome and pathway data with unique signatures. The Immune Evasion vs. Neoantigen Silencing Module uses a tumor dynamics model to assess immunotherapy resistance. The Immunotherapy Sensitivity Calculation (ISC) estimates treatment effectiveness based on Tumor Mutational Burden (TMB), immune checkpoint activity, HLA expression, markers of immunogenic cell death, and mRNA vaccine responsiveness. Mamdani and Sugeno systems enable transparent clinical decision-making. The Image and Data Analysis module assesses tumor cell proliferation and morphology through geometric modeling. The Classification Process employs ensemble methods and SVM classifiers, optimized with MobileNetV3-Small feature vectors. A Hierarchical Multi-Scale Transformer (HMT) learns semantic representations across scales. Additionally, a Semi-Supervised Adversarial Learning Mechanism improves biomarker prediction using labeled and unlabeled data. The Multi-Objective Loss Function Framework integrates focal classification loss, modality-specific learning loss, and cosine alignment loss for effective feature fusion and reliable predictions.

The International Journal of Maritime EngineeringVol. 168(A6(S))
Vignana Bharathi Institute of Technology (IN)
Good health and well-being
Cancer Immunotherapy and Biomarkers
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon